Madhu Kumar

Stock Analyst at Goldman Sachs

(2.89)
# 1,765
Out of 5,044 analysts
151
Total ratings
56.86%
Success rate
20.34%
Average return

Stocks Rated by Madhu Kumar

Jazz Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $162$185
Current: $135.73
Upside: +36.30%
Fulcrum Therapeutics
Jan 26, 2024
Maintains: Neutral
Price Target: $5$6
Current: $9.36
Upside: -35.90%
Informatica
Dec 7, 2023
Maintains: Neutral
Price Target: $23$26
Current: $24.85
Upside: +4.63%
Utz Brands
Nov 10, 2023
Maintains: Neutral
Price Target: $19$17
Current: $11.95
Upside: +42.26%
Alector
Sep 25, 2023
Initiates: Sell
Price Target: $4
Current: $1.55
Upside: +158.06%
Krystal Biotech
May 22, 2023
Maintains: Buy
Price Target: $135$155
Current: $185.05
Upside: -16.24%
Cytokinetics
May 5, 2023
Maintains: Buy
Price Target: $48$53
Current: $61.99
Upside: -14.50%
Design Therapeutics
May 4, 2023
Upgrades: Neutral
Price Target: n/a
Current: $6.49
Upside: -
Arrowhead Pharmaceuticals
May 3, 2023
Maintains: Buy
Price Target: $65$73
Current: $40.29
Upside: +81.19%
Apellis Pharmaceuticals
Apr 14, 2023
Maintains: Buy
Price Target: $124$141
Current: $30.05
Upside: +369.22%
Maintains: Buy
Price Target: $39$34
Current: $13.22
Upside: +157.19%
Downgrades: Neutral
Price Target: $20$6
Current: $2.00
Upside: +200.00%
Maintains: Sell
Price Target: $8$14
Current: $9.44
Upside: +48.31%
Maintains: Buy
Price Target: $24$21
Current: $10.30
Upside: +103.88%
Downgrades: Sell
Price Target: $5
Current: $16.33
Upside: -69.38%
Maintains: Sell
Price Target: $10$8
Current: $3.04
Upside: +163.16%
Maintains: Buy
Price Target: $111$89
Current: $9.59
Upside: +828.05%
Downgrades: Neutral
Price Target: $580$120
Current: $7.43
Upside: +1,515.07%
Downgrades: Sell
Price Target: $10
Current: $1.22
Upside: +719.67%
Maintains: Neutral
Price Target: $60$85
Current: $13.12
Upside: +547.87%
Upgrades: Outperform
Price Target: $23$39
Current: $3.63
Upside: +974.38%
Upgrades: Outperform
Price Target: $58$57
Current: $70.59
Upside: -19.25%
Downgrades: Neutral
Price Target: n/a
Current: $4.61
Upside: -
Initiates: Outperform
Price Target: $900
Current: $1.45
Upside: +61,968.97%
Maintains: Underperform
Price Target: $17$20
Current: $5.91
Upside: +238.41%
Maintains: Buy
Price Target: $140$100
Current: $0.75
Upside: +13,224.45%
Initiates: Outperform
Price Target: $35
Current: $29.27
Upside: +19.58%
Initiates: Outperform
Price Target: $60
Current: $0.48
Upside: +12,449.68%
Maintains: Buy
Price Target: $58$40
Current: $11.73
Upside: +241.01%
Upgrades: Buy
Price Target: $504
Current: $30.99
Upside: +1,526.33%
Maintains: Buy
Price Target: $210$230
Current: $481.59
Upside: -52.24%
Maintains: Buy
Price Target: $150$1,125
Current: $12.50
Upside: +8,900.00%
Initiates: Buy
Price Target: $40
Current: $1.38
Upside: +2,798.55%
Reinstates: Buy
Price Target: $22
Current: $33.78
Upside: -36.35%
Initiates: Buy
Price Target: $24
Current: $62.56
Upside: -62.44%